Skip to main content
Clinical Trials/NCT02371486
NCT02371486UnknownNot Applicable

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

Sheba Medical Center1 site in 1 country150 target enrollmentStarted: April 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Locations
1
Primary Endpoint
Embryo implantation rate

Study Overview

Brief Summary

Cesarean scar defects (CSDs), i.e. deficient uterine scars following a cesarean section, involve discontinuity at the site of a previous Cesarean section scar. These anatomical defects have been reported to be associated with postmenstrual spotting, chronic pelvic pain and infertility. Few case series have suggested improved fertility (most probably by improving implantation of embryos) The aim of this study is to prospectively record embryonal implantation rate during IVF in patients with CSDs, and to evaluate the effect of hysteroscopic repair of CSDs on fetal implantation during IVF.

Detailed Description

150 patients undergoing IVF after cesarean section will be recruited. demographic, clinical and treatment data will be collected. ultrasound and hysteroscopic evaluation of the CSD will be performed. IVF treatment will be provided. In case of failure of IVF treatment, patients will be randomized to hysteroscopic repair of CSD versus second IVF treatment

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients undergoing IVF after cesarean section

Exclusion Criteria

  • •Patients who underwent CSD repair
  • •Patients with low ovarian reserve
  • •Patients with hydrosalpinges, endometriosis, adenomyosis, submucous fibroids or polyps

Arms & Interventions

Nich Repair

Experimental

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. hysteroscopic repair of cesarean section defect
  4. IVF cycle

Intervention: IVF Cycle (Procedure)

No Repair

Sham Comparator

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. IVF cycle Operative hysteroscopy WILL NOT BE PERFORMED

Intervention: Diagnostic Hysteroscopy (Procedure)

No Repair

Sham Comparator

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. IVF cycle Operative hysteroscopy WILL NOT BE PERFORMED

Intervention: Ultrasound Scan (Procedure)

No Repair

Sham Comparator

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. IVF cycle Operative hysteroscopy WILL NOT BE PERFORMED

Intervention: IVF Cycle (Procedure)

Nich Repair

Experimental

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. hysteroscopic repair of cesarean section defect
  4. IVF cycle

Intervention: hysteroscopic repair of cesarean section defect (Procedure)

Nich Repair

Experimental

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. hysteroscopic repair of cesarean section defect
  4. IVF cycle

Intervention: Diagnostic Hysteroscopy (Procedure)

Nich Repair

Experimental

Interventions to be administered:

  1. Ultrasound Scan
  2. Diagnostic Hysteroscopy
  3. hysteroscopic repair of cesarean section defect
  4. IVF cycle

Intervention: Ultrasound Scan (Procedure)

Outcomes

Primary Outcomes

Embryo implantation rate

Time Frame: completion of two IVF cycles after randomization - approx. 2 months

Embryo implantation rate during IVF

Secondary Outcomes

  • Fluid in Uterus(completion of two IVF cycles after randomization - approx. 2 months)
  • Correlation between the size and type of the defect and implantation rate during IVF treatment(completion of two IVF cycles after randomization - approx. 2 months)
  • Correlation between size and type of the defect fluid accumulation(completion of two IVF cycles after randomization - approx. 2 months)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Roy Mashiach, M.D.

Vice Chairman Gynecological Department

Sheba Medical Center

Study Sites (1)

Loading locations...

Similar Trials